WSAZ-TV |
Mylan CEO defends price boosts of lifesaving EpiPen
USA TODAY ... nonpartisan Center for Healthcare Research and Transformation, said Mylan's profit margin on the EpiPen will fluctuate depending on the payer. But based on the volume of sales, it's a "considerable profit for the company," Udow-Phillips told USA TODAY. USA Today reports Gayle Manchin used position to boost EpiPen sales Family matters: EpiPens had high-level help getting into schools How Much Has Medicare Spent on the EpiPen Since 2007? |
